
Linzagolix - Endometriosis
You are here : Home > Formulary Search > Linzagolix - Endometriosis
Documentation
PAD Profile
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed implementation of linzagolix for treating the symptoms of endometriosis in line with NICE TA1067.
Linzagolix for this indication will be considered as BLUE (following specialist team initiation) on the traffic light system. Specialist will be expected to prescribe a minimum of 1 month of linzagolix before requesting transfer of care to the primary care prescriber.
A DXA scan is recommended after the first 52 weeks of treatment to verify that the patient does not have an unwanted degree of BMD loss, that exceeds the benefit of treatment. This DXA scan will be organised & performed by the specialist team responsible for the ongoing care of the patient
Other Indications
Below are listed other indications that Linzagolix is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Endometriosis.